| abstract |
COMPOUNDS, PROCESS FOR THEIR MANUFACTURE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, METHOD FOR THE THERAPEUTIC AND / OR PROPHYLACTIC TREATMENT OF DISEASES THAT ARE MODULATED BY L-CPT1 INHIBITORS AND USES OF THE COMPOUNDS The invention relates to new heterobyclic derivatives of the formula I) where R ^ 1 ^, R ^ 2 ^, R ^ 3 ^, R ^ 4 ^, R ^ 5 ^, R ^ 6 ^, V, W, X and Y are as defined in the description and in the claims , as well as their physiologically acceptable salts and esters. These compounds inhibit L-CPT1 and can be used as Medicines. |